Citigroup
ARAV

Citigroup’s Aravive, Inc. Common Stock ARAV Stock Holding History

Citigroup’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,988
Closed -$29K – 5964
2022
Q4 		$29K Buy
+21,988
New +$28.1K ﹤0.01% 4464
2022
Q2 		– Sell
-1,479
Closed -$3K – 6799
2022
Q1 		$3K Buy
+1,479
New +$3.19K ﹤0.01% 6010
2021
Q3 		– Sell
-1
Closed – – 6414
2021
Q2 		$0 Sell
1
-805
-100% -$4.26K ﹤0.01% 6482
2021
Q1 		$5K Sell
806
-1,518
-65% -$9.98K ﹤0.01% 5916
2020
Q4 		$13K Buy
2,324
+1,739
+297% +$9.54K ﹤0.01% 6877
2020
Q3 		$3K Sell
585
-1,049
-64% -$7.45K ﹤0.01% 7249
2020
Q2 		$19K Buy
+1,634
New +$19.4K ﹤0.01% 6671
2020
Q1 		– Sell
-253
Closed -$3K – 7815
2019
Q4 		$3K Buy
+253
New +$2.24K ﹤0.01% 7511
2018
Q2 		– Sell
-674
Closed -$7K – 7781
2018
Q1 		$7K Buy
674
+86
+15% +$968 ﹤0.01% 7149
2017
Q4 		$8K Sell
588
-3,784
-87% -$48.7K ﹤0.01% 7125
2017
Q3 		$64K Buy
4,372
+2,880
+193% +$291K ﹤0.01% 5869
2017
Q2 		$156K Sell
1,492
-422
-22% -$45.3K ﹤0.01% 4994
2017
Q1 		$245K Sell
1,914
-5,291
-73% -$558K ﹤0.01% 4495
2016
Q4 		$644K Buy
7,205
+4,875
+209% +$369K ﹤0.01% 4120
2016
Q3 		$171K Buy
2,330
+504
+28% +$36.4K ﹤0.01% 4782
2016
Q2 		$121K Sell
1,826
-2,442
-57% -$139K ﹤0.01% 4925
2016
Q1 		$205K Buy
4,268
+1,328
+45% +$70.4K ﹤0.01% 5072
2015
Q4 		$219K Buy
2,940
+1,385
+89% +$92.9K ﹤0.01% 4662
2015
Q3 		$108K Sell
1,555
-298
-16% -$28K ﹤0.01% 4925
2015
Q2 		$169K Buy
1,853
+115
+7% +$11.7K ﹤0.01% 4565
2015
Q1 		$191K Buy
1,738
+60
+4% +$7.04K ﹤0.01% 4572
2014
Q4 		$226K Buy
1,678
+1,619
+2,744% +$189K ﹤0.01% 4583
2014
Q3 		$7K Buy
59
+38
+181% +$5.04K ﹤0.01% 6432
2014
Q2 		$3K Buy
+21
New +$3.63K ﹤0.01% 6659

Other funds holding ARAV

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citigroup's ARAV Position: Q1 2023 in Review

Citigroup sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2023, closing a stake of 21,988 shares — an estimated $29K sold.

Citigroup first reported a position in ARAV in Q2 2014 and held it in 24 quarters. The position peaked at $644K in Q4 2016. 36 funds tracked by Wall St. Rank hold ARAV as of Q1 2023.

  • Citigroup reported no remaining Aravive, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 21,988 Aravive, Inc. Common Stock shares in Q1 2023, an estimated $29K.
  • Citigroup first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 24 quarters.
  • Citigroup's Aravive, Inc. Common Stock position peaked at $644K in Q4 2016.
  • 36 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.